The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Transformative Impact of AI on Pharmaceutical Supply Chain Management: Revolutionizing Agility Through Dynamic Capabilities, IBP, and S&OP
Abstract
The pharmaceutical supply chain is characterized by mounting intricacy and the necessity for expeditious responses to fluctuating market conditions, regulatory constraints, and disruptions. The advent of Artificial Intelligence (AI) has been identified as a transformative force, with the potential to enhance organizational agility through dynamic capabilities (DC), Integrated Business Planning (IBP), and Sales and Operations Planning (S&OP). This chapter develops a comprehensive theoretical framework to examine the intersection of AI, pharmaceutical supply chain management, and DC, addressing a critical gap in understanding how AI-driven technologies can revolutionize agility and strategic alignment.
Related Content
|
Frederic Andres.
© 2027.
14 pages.
|
|
Kalsoom Safdar, Khairul Najmy Abdul Rani, Mohd Aminudin Jamlos, Siti Julia Rosli, Muhammad Usman Younus, Zanab Safdar.
© 2027.
27 pages.
|
|
Bani Adam, Binastya Anggara Sekti, Muhammad Adi Zacky Zahran.
© 2027.
24 pages.
|
|
Swetha Margaret T. A., Renuka Devi D..
© 2027.
31 pages.
|
|
Maurice Saluschke, Michael Schulz.
© 2027.
30 pages.
|
|
Mirjam Sepesy Maučec, Gregor Donaj.
© 2027.
16 pages.
|
|
Jorge A. Ruiz-Vanoye, Ocotlan Diaz-Parra, Ricardo A. Barrera-Cámara, Alejandro Fuentes-Penna, Francisco R. Trejo-Macotela, Jaime Aguilar-Ortiz, Eric Simancas-Acevedo.
© 2027.
21 pages.
|
|
|